Haemonetics (HAE) Net Margin (2009 - 2026)
Haemonetics' quarterly Net Margin came in at 5.81% in Q1 2026, down 2335.0% year-on-year from 0.26% in Q1 2025, and down 143.98% quarter-over-quarter from 13.21% in Q4 2025.
Haemonetics has reported Net Margin for 18 years, with the latest figure at 5.81% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 2335.0% year-over-year to 5.81%; the trailing twelve-month figure through Mar 2026 stood at 7.3% (down 503.0% YoY), and the FY2026 full-year result was 7.29%, down 503.0% from the prior year.
- Net Margin for Q1 2026 stood at 5.81%, down from 13.21% in the prior quarter.
- The five-year high for Net Margin was 17.54% in Q1 2025, with the low at 5.81% in Q1 2026.
- Average Net Margin over 5 years is 9.3%, with a median of 10.19% recorded in 2025.
- Year-over-year, Net Margin soared 1159 bps in 2025 and sank 2335 bps in 2026.
- Tracing HAE's Net Margin over 5 years: stood at 10.79% in 2022, then declined by 14 bps to 9.29% in 2023, then advanced by 16 bps to 10.76% in 2024, then grew by 23 bps to 13.21% in 2025, then slumped by 144 bps to 5.81% in 2026.
- The last three Net Margin figures came in at 5.81% (Q1 2026), 13.21% (Q4 2025), and 11.82% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Haemonetics | 3.18 Bn | 2.93 Bn | 198.21 Mn | -5.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -5.81% |
| Dec 27, 2025 | 13.21% |
| Sep 27, 2025 | 11.82% |
| Jun 28, 2025 | 10.59% |
| Mar 29, 2025 | 17.54% |
| Dec 28, 2024 | 10.76% |
| Sep 28, 2024 | 9.79% |
| Jun 29, 2024 | 11.41% |
| Mar 30, 2024 | 5.93% |
| Dec 30, 2023 | 9.29% |
| Sep 30, 2023 | 7.84% |
| Jul 1, 2023 | 13.18% |
| Apr 1, 2023 | 9.65% |
| Dec 31, 2022 | 10.79% |
| Oct 1, 2022 | 11.16% |
| Jul 2, 2022 | 7.61% |
| Apr 2, 2022 | 3.69% |
| Jan 1, 2022 | 8.93% |
| Oct 2, 2021 | 6.19% |
| Jul 3, 2021 | -1.95% |
| Apr 3, 2021 | -4.91% |
| Dec 26, 2020 | 13.26% |
| Sep 26, 2020 | 22.94% |
| Jun 27, 2020 | 5.36% |
| Mar 28, 2020 | 7.39% |
| Dec 28, 2019 | 11.56% |
| Sep 28, 2019 | 14.84% |
| Jun 29, 2019 | -3.56% |
| Mar 30, 2019 | 8.35% |
| Dec 29, 2018 | 7.38% |
| Sep 29, 2018 | 7.76% |
| Jun 30, 2018 | -1.23% |
| Mar 31, 2018 | 5.09% |
| Dec 30, 2017 | -2.80% |
| Sep 30, 2017 | 8.92% |
| Jul 1, 2017 | 9.55% |
| Apr 1, 2017 | -22.42% |
| Dec 31, 2016 | 6.76% |
| Oct 1, 2016 | 9.00% |
| Jul 2, 2016 | -4.93% |
| Apr 2, 2016 | -3.60% |
| Dec 26, 2015 | -25.46% |
| Sep 26, 2015 | 5.86% |
| Jun 27, 2015 | -0.13% |
| Mar 28, 2015 | -1.29% |
| Dec 27, 2014 | 6.90% |
| Sep 27, 2014 | 3.29% |
| Jun 28, 2014 | -1.63% |
| Mar 29, 2014 | 4.22% |
| Dec 28, 2013 | 6.73% |
| Sep 28, 2013 | 7.02% |
| Jun 29, 2013 | -3.59% |
| Mar 30, 2013 | 5.03% |
| Dec 29, 2012 | 4.00% |
| Sep 29, 2012 | 3.00% |
| Jun 30, 2012 | 5.55% |
| Mar 31, 2012 | 9.54% |
| Dec 31, 2011 | 9.55% |
| Oct 1, 2011 | 7.73% |
| Jul 2, 2011 | 9.94% |
| Apr 2, 2011 | 12.34% |
| Jan 1, 2011 | 11.16% |
| Oct 2, 2010 | 12.79% |
| Jul 3, 2010 | 10.99% |
| Apr 3, 2010 | 2.34% |
| Dec 26, 2009 | 11.07% |
| Sep 26, 2009 | 11.49% |
| Jun 27, 2009 | 11.73% |